Revumenib (SNDX-5613): a promising menin inhibitor for the management of relapsed and refractory acute myeloid leukaemia (AML)

被引:2
作者
Hussain, Harmla [1 ]
Zaidi, Syeda Mahrukh Fatima [1 ]
Hasan, Syed Mohammad [1 ]
Jahan, Aelia Sarv [1 ]
Rangwala, Burhanuddin Sohail [2 ]
Rangwala, Hussain Sohail [2 ]
Ali, Mirha [2 ]
Farah, Asma Ahmed [3 ,4 ]
机构
[1] Dr Ruth KM Pfau Civil Hosp Karachi, Dept Surg Unit 6, Karachi, Pakistan
[2] Jinnah Sindh Med Univ, Dept Med, Karachi, Pakistan
[3] East Africa Univ, Dept Med, Boosaaso, Somalia
[4] East Africa Univ, 66R3 CC4, Boosaaso, Somalia
关键词
D O I
10.1097/MS9.0000000000001888
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2379 / 2381
页数:3
相关论文
共 16 条
[1]  
Aldoss I., 2023, BLOOD, P142, DOI [10.1182/blood-2023-192042, DOI 10.1182/BLOOD-2023-192042]
[2]   Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo [J].
Borkin, Dmitry ;
He, Shihan ;
Miao, Hongzhi ;
Kempinska, Katarzyna ;
Pollock, Jonathan ;
Chase, Jennifer ;
Purohit, Trupta ;
Malik, Bhavna ;
Zhao, Ting ;
Wang, Jingya ;
Wen, Bo ;
Zong, Hongliang ;
Jones, Morgan ;
Danet-Desnoyers, Gwenn ;
Guzman, Monica L. ;
Talpaz, Moshe ;
Bixby, Dale L. ;
Sun, Duxin ;
Hess, Jay L. ;
Muntean, Andrew G. ;
Maillard, Ivan ;
Cierpicki, Tomasz ;
Grembecka, Jolanta .
CANCER CELL, 2015, 27 (04) :589-602
[3]   An update of current treatments for adult acute myeloid leukemia [J].
Dombret, Herve ;
Gardin, Claude .
BLOOD, 2016, 127 (01) :53-61
[4]   Update on a Phase 1/2 First-in-Human Study of the Menin-KMT2A (MLL) Inhibitor Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia [J].
Erba, Harry P. ;
Fathi, Amir T. ;
Issa, Ghayas C. ;
Altman, Jessica K. ;
Montesinos, Pau ;
Patnaik, Mrinal M. ;
Foran, James M. ;
De Botton, Stephane ;
Baer, Maria R. ;
Schiller, Gary J. ;
Walter, Roland B. ;
Kremyanskaya, Marina ;
Pettit, Kristen M. ;
Strickland, Stephen A. ;
Tomkinson, Blake ;
Tabachri, Marilyn ;
Leoni, Mollie ;
Dale, Stephen ;
Wang, Eunice S. .
BLOOD, 2022, 140
[5]   NPM1-mutated acute myeloid leukemia: from bench to bedside [J].
Falini, Brunangelo ;
Brunetti, Lorenzo ;
Sportoletti, Paolo ;
Martelli, Maria Paola .
BLOOD, 2020, 136 (15) :1707-1721
[6]   Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2 Analysis of a Phase 1/2 Study [J].
Fathi, Amir T. ;
DiNardo, Courtney D. ;
Kline, Irina ;
Kenvin, Laurie ;
Gupta, Ira ;
Attar, Eyal C. ;
Stein, Eytan M. ;
de Botton, Stephane .
JAMA ONCOLOGY, 2018, 4 (08) :1106-1110
[7]   Minimal residual disease in acute myeloid leukaemia [J].
Hourigan, Christopher S. ;
Karp, Judith E. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (08) :460-471
[8]   The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia [J].
Issa, Ghayas C. ;
Aldoss, Ibrahim ;
DiPersio, John ;
Cuglievan, Branko ;
Stone, Richard ;
Arellano, Martha ;
Thirman, Michael J. ;
Patel, Manish R. ;
Dickens, David S. ;
Shenoy, Shalini ;
Shukla, Neerav ;
Kantarjian, Hagop ;
Armstrong, Scott A. ;
Perner, Florian ;
Perry, Jennifer A. ;
Rosen, Galit ;
Bagley, Rebecca G. ;
Meyers, Michael L. ;
Ordentlich, Peter ;
Gu, Yu ;
Kumar, Vinit ;
Smith, Steven ;
McGeehan, Gerard M. ;
Stein, Eytan M. .
NATURE, 2023, 615 (7954) :920-+
[9]  
Katona Bryson W, 2019, Oncoscience, V6, P368, DOI 10.18632/oncoscience.485
[10]   Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia [J].
Lo-Coco, F. ;
Avvisati, G. ;
Vignetti, M. ;
Thiede, C. ;
Orlando, S. M. ;
Iacobelli, S. ;
Ferrara, F. ;
Fazi, P. ;
Cicconi, L. ;
Di Bona, E. ;
Specchia, G. ;
Sica, S. ;
Divona, M. ;
Levis, A. ;
Fiedler, W. ;
Cerqui, E. ;
Breccia, M. ;
Fioritoni, G. ;
Salih, H. R. ;
Cazzola, M. ;
Melillo, L. ;
Carella, A. M. ;
Brandts, C. H. ;
Morra, E. ;
von Lilienfeld-Toal, M. ;
Hertenstein, B. ;
Wattad, M. ;
Luebbert, M. ;
Haenel, M. ;
Schmitz, N. ;
Link, H. ;
Kropp, M. G. ;
Rambaldi, A. ;
La Nasa, G. ;
Luppi, M. ;
Ciceri, F. ;
Finizio, O. ;
Venditti, A. ;
Fabbiano, F. ;
Doehner, K. ;
Sauer, M. ;
Ganser, A. ;
Amadori, S. ;
Mandelli, F. ;
Doehner, H. ;
Ehninger, G. ;
Schlenk, R. F. ;
Platzbecker, U. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02) :111-121